Edwards Lifesciences reported $955.3M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8983M 107M
Abiomed ABMD:US $ 204.85M 8.24M
Becton, Dickinson and BDX:US $ 4359M 179M
Cooper Companies COO:US $ 656.4M 25.8M
Globus Medical GMED:US $ 184.1M 47.72M
Inogen INGN:US $ 93.97M 10.9M
Insulet PODD:US $ 257.5M 1.3M
Integra Lifesciences IART:US $ 329.18M 23.9M
Masimo MASI:US $ 244.5M 5.67M
Stryker SYK:US $ 3.83B 58M
Tandem Diabetes Care TNDM:US $ 191.24M 6.01M